Newsletters
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
Nature publishes superb 10-paper collection on all things AMR
Dear All, Released on 21 Oct 2020, Nature has published has published an Outlook series on AMR. The papers are …
NIAID Small Business Application Assistance Program seeks applications!
Dear All, National Institute of Allergy and Infectious Diseases (NIAID) put out a call on 22 Oct 2020 for applications for …
FDA workshop: Insights on inhaled antifungals and antibacterials
Dear All (wonkish alert … coffee up!), FDA held a workshop on 25 Sep 2020 on development of inhaled antifungal …
FDA workshop: Revising the process for importance-ranking of human antimicrobials to guide their use in animals
Dear All, FDA have announced that they will hold a virtual public workshop on 16 Nov 2020 (9.30a-4.00p EST) entitled “Potential …
US National Action Plan for Combatting AMR: 2020-25 update!
Dear All (and with thanks to Kevin Outterson for doing the heavy lifting on this note), As you may recall, …
WHO to create a Priority Pathogen List for Fungi! / RFP to build the list
Dear All, WHO have been thinking about the threat of resistant fungi as well as resistant bacteria. An initial discussion …
Help (re)validate WHO’s Priority Pathogens List and Essential Medicines List
Dear All, The Drug-Resistant Infections team at Wellcome Trust (link to their homepage) has launched a survey collecting data on …
BARDA seeks information: Are you creating an antibiotic for Yersinia or other biothreat Gram-negatives?
Dear All, BARDA is interested in hearing from antibiotic developers about antibiotics which could be used under Emergency Use Authorization …
Health Security underpins Economic Security: Fabulous webinar chaired by Dame Sally
Dear All, I want to call your attention to the replay available on YouTube of the excellent 24 Sep 2020 …
PASTEUR Act (re)introduced: A delinked Pull award advances in the US!
Dear All (with thanks to Kevin Outterson for leading this note), HUGE news today: Senator Michael F. Bennet and Senator Todd …
Help Alan Carr with a point survey on COVID-19 vaccines!
Dear All, Once again, we’re going to have a brief change from our usual programming with this newsletter. I hope you …
In Praise of Non-Inferiority
Dear All (wonkish but intended for everybody to read and absorb): There’s been a lot of recent discussion about “lessons learned …
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
Dear All (lots and lots of wonkish detail here, be sure your blood caffeine level is adequate!), During the 24-28 Aug …
Treating resistant Gram-negatives: IDSA provides pragmatic expert advice
Dear All, IDSA (Infectious Diseases Society of America) have today released an eagerly awaited new guidance document on treating infections …
New antibiotics are not being registered or sold in Europe in a timely manner
Dear All (and with thanks to Kevin for leading the charge on this newsletter), While listening to last week’s BEAM-sponsored …
Dame Sally and #RescueTheLobster: Meetings past and present worth your time
Dear All, There’s a tidal wave of meetings for you to note! Some have already occurred but can easily be …
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
Dear All (with thanks to Kevin as the lead author on this note and also with a wonkish note alert …
EMA Network Strategy to 2025: Action on AMR / Comments due 4 Sep
Dear All, We learned today during the BEAM AMR conference (link) that EMA released a call on 7 June 202 for …
Global AMR Hub launches Incentives Gallery / AMR Conference is underway
Dear All, In case you missed it, the 4th AMR Conference sponsored by BEAM, CARB-X, Novo REPAIR, Wellcome Trust, the …
Alan Carr’s August ’20 Antibiotic-Antifungal update: Required reading!
Dear All, I hope everyone is finding a bit of time to go off-line during August … always a good …
